New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial
Cancer Patients Who Die In Hospital Or ICU Have Worse QOL; Caregivers Affected, Too
Rituximab Prolonged Survival Of CLL In Phase III Study
A Low-Cost Vaccine To Enter Clinical Trials In A Year
HPV DNA Testing Reduced Cervical Cancer Precursors
Targeting Men At High Risk Finds More Head & Neck Cancer
Half Of Mexican-Origin Women With Breast Cancer Diagnosed Before Age 50, Study Finds
Multivitamin Use Doesn’t Impact Outcomes, Study Finds
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer patients with Medicare Advantage have access to fewer providers than Medicare patients, cross-sectional study finds
- Did peer review fail? Nature Medicine’s chronotherapy paper retraction raises questions
- A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m. - OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill
- A new diagnostic lens—and a lasting scientific legacy









